Category: Biolase Technology Inc.Syndicate content

UPDATE: Court cuts Biolase board, marketing VP under fire

March 24, 2014 by Arezu Sarvestani

A Delaware state judge cuts the number of directors at Biolase and constrains the board's decision-making powers, as the dental device maker's claims about its sales & marketing vice president come under fire from a former employer amid a proxy war.

Court halves Biolase board, marketing VP under fire

*Updated March 25, 2014 at 10 a.m. Eastern with comment from Biolase sales & marketing vice president Brian Jaffe.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Proxy war brews as activist investor Oracle targets Biolase board

March 17, 2014 by Arezu Sarvestani

Biolase steadies itself against a proxy war filed by activist majority shareholder Oracle Partners over alleged manipulation of the board of directors.

Proxy war brews as activist investor Oracle targets Biolase leadership

Biolase cuts costs ahead of a potential sale, posts losses in Q4

March 11, 2014 by Arezu Sarvestani

Medical lasers maker Biolase is still examining "strategic alternatives" for the company as its slashes about $1.3 million from its payroll and posts continued quarterly losses.

Biolase cuts costs ahead of a potential sale, posts losses in Q4

California medtech company Biolase (NSDQ:BIOL) is looking to slim down ahead of a potential acquisition as the company examines its "strategic alternatives."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp